Hubei Jumpcan Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 646.76 M

Hubei Jumpcan Pharmaceutical Co., Ltd. Current Liabilities is USD 646.76 M for the year ending December 31, 2023, a 30.23% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Hubei Jumpcan Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 496.65 M, a 12.68% change year over year.
Hubei Jumpcan Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 440.76 M, a 46.26% change year over year.
Hubei Jumpcan Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 301.35 M, a 14.06% change year over year.
Hubei Jumpcan Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 264.21 M, a 8.95% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Shanghai Stock Exchange: 600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

CEO	Mr. Fei Cao
IPO Date	Aug. 22, 2001
Location	China
Headquarters	Baota Bay
Employees	5,230
Sector	Health Care
Industries Pharmaceuticals

Description

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis. The company was formerly known as Hubei Hongcheng General Machinery Co., Ltd and changed its name to Hubei Jumpcan Pharmaceutical Co., Ltd. in March 2015. Hubei Jumpcan Pharmaceutical Co., Ltd. is based in Taixing, China.

Key trends

Past 5 years